Cooperative Adenomyosis Network
CAN
A Study of Cooperative Network of Diagnosis and Treatment of Uterine Adenomyosis.
1 other identifier
observational
5,000
1 country
1
Brief Summary
To set up a Cooperative Network by enrolling 5000 patients with Adenomyosis(AM) from multiple centers.Based on the Network platform and Database,the investigators try to explore the diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In addiction,the investigators expect to conduct research on the effect and the follow-up fertility outcomes of different medical or surgical treatment, the etiology of AM and endometriosis,the perspective investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to chinese conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2017
CompletedStudy Start
First participant enrolled
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedNovember 13, 2018
November 1, 2018
3 years
June 30, 2017
November 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Therapeutic effect and Diagnostics
Symptom Assessment
2day
Secondary Outcomes (6)
Pathology
1day
selection of therapeutic scheme
1day
vision algetic standard(VAS)
2day
B type ultrasound
1day
Magnetic Resonance Imaging
1day
- +1 more secondary outcomes
Study Arms (1)
Different Treatment Groups
Women would receive different pharmacotherapy from the standard approach,such as levonorgestrel-releasing intrauterine system(LNG-IUS),Gonadotrophin releasing hormone agonist(GnRH-a),surgery,etc.
Eligibility Criteria
5000 women diagnosed of adenomyosis by pathology or magnetic resonance image(MRI)by experienced specialist physicians will be enrolled from nationwide multicenter.
You may qualify if:
- Women diagnosed of adenomyosis by pathology, transvaginal ultrasound or MRI.
You may not qualify if:
- Refusal to join the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lei Li
Beijing, China/Beiing, 100000, China
Related Publications (8)
Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol. 2016 Feb 1;23(2):164-85. doi: 10.1016/j.jmig.2015.09.018. Epub 2015 Sep 30.
PMID: 26427702BACKGROUNDAlabiso G, Alio L, Arena S, Barbasetti di Prun A, Bergamini V, Berlanda N, Busacca M, Candiani M, Centini G, Di Cello A, Exacoustos C, Fedele L, Fuggetta E, Gabbi L, Geraci E, Imperiale L, Lavarini E, Incandela D, Lazzeri L, Luisi S, Maiorana A, Maneschi F, Mannini L, Mattei A, Muzii L, Pagliardini L, Perandini A, Perelli F, Pinzauti S, Porpora MG, Remorgida V, Leone Roberti Maggiore U, Seracchioli R, Solima E, Somigliana E, Tosti C, Venturella R, Vercellini P, Vigano P, Vignali M, Zannoni L, Zullo F, Zupi E; Endometriosis Treatment Italian Club. Adenomyosis: What the Patient Needs. J Minim Invasive Gynecol. 2016 May-Jun;23(4):476-88. doi: 10.1016/j.jmig.2015.12.017. Epub 2016 Jan 6.
PMID: 26772777BACKGROUNDVercellini P, Consonni D, Barbara G, Buggio L, Frattaruolo MP, Somigliana E. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reprod Biomed Online. 2014 Jun;28(6):704-13. doi: 10.1016/j.rbmo.2014.02.006. Epub 2014 Mar 4.
PMID: 24745831RESULTPontis A, D'Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016 Sep;32(9):696-700. doi: 10.1080/09513590.2016.1197200. Epub 2016 Jul 5.
PMID: 27379972RESULTLi L, Leng JH, Shi JH, Zhang JJ, Jia SZ, Li XY, Dai Y, Zhang JR, Li T, Xu XX, Liu ZZ, You SS, Chang XY, Lang JH. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia]. Zhonghua Fu Chan Ke Za Zhi. 2016 Jun 25;51(6):424-30. doi: 10.3760/cma.j.issn.0529-567X.2016.06.005. Chinese.
PMID: 27356477RESULTSakhel K, Abuhamad A. Sonography of adenomyosis. J Ultrasound Med. 2012 May;31(5):805-8. doi: 10.7863/jum.2012.31.5.805. No abstract available.
PMID: 22535729RESULTLevy G, Dehaene A, Laurent N, Lernout M, Collinet P, Lucot JP, Lions C, Poncelet E. An update on adenomyosis. Diagn Interv Imaging. 2013 Jan;94(1):3-25. doi: 10.1016/j.diii.2012.10.012. Epub 2012 Dec 12.
PMID: 23246186RESULTChen X, Lang J, Li L. Adenomyosis Patterns on Transvaginal Sonography Could Predict the Obstetrical Outcomes of Fertility-Sparing Surgeries: A Retrospective Cohort Study. J Minim Invasive Gynecol. 2025 Jun;32(6):540-549. doi: 10.1016/j.jmig.2025.01.003. Epub 2025 Jan 11.
PMID: 39805535DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aijun AJ SUN, MD
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 27, 2017
Study Start
June 30, 2017
Primary Completion
June 30, 2020
Study Completion
December 30, 2020
Last Updated
November 13, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR, ANALYTIC CODE
- Time Frame
- Within twelve months after the trial complete
- Access Criteria
- Data access requests will be reviewed by an external independent review panel.Requestors will be required to sign a Data Access Agreement.
Network platform, and the website will be attached later.